Adjuvant treatment of brain metastases

Seminars in Surgical Oncology

Volumn 20, Issue 1, 2001, Pages 50-56

  Lohr, Frank ^a,d   Pirzkall, Andrea ^b   Hof, Holger ^a   Fleckenstein, Katharina ^a   Debus, Jürgen ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Dept of Clinical Radiology ^*  (Germany)

Author keywords

Brain neoplasms; Combined modality therapy; Neoplasm metastases; Radiosurgery; Radiotherapy; Radiotherapy adjuvant; Surgery

Indexed keywords

STEROID;

BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; PALLIATIVE THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SALVAGE THERAPY; STEREOTAXIC SURGERY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 0035050254     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1016     Document Type: Review

References (44)

1. Brain metastases. An autopsy study
2. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group
3. A report of the consensus workshop panel on the treatment of brain metastases
4. Radiotherapy for cerebral metastases
5. Roentgen-ray therapy of cerebral metastases
6. A randomized trial of surgery in the treatment of single metastases to the brain
7. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916
8. The results of the radiotherapy of brain metastases in patients at an advanced age
9. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients
10. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials
11. CT characteristics of patients with brain metastases treated in RTOG study 79-16
12. The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the Radiation Therapy Oncology Group
13. Dose/effect relationships for brain metastases
14. Accelerated radiotherapy for brain metastases
15. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)
16. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28
17. Radiation-induced dementia in patients cured of brain metastases
18. Solitary brain metastasis: Results of an RTOG/SWOG protocol evaluation surgery + RT versus RT alone
19. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: Association with pattern of failure and survival
20. The role of postoperative radiotherapy after resection of single brain metastases
21. Single brain metastases: Surgery plus radiation or radiation alone
22. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis
23. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age
24. Long-term follow-up for brain metastases treated by percutaneous stereotactic single highdose irradiation
25. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases
26. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases
27. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
28. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis
29. Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control
30. Solitary brain metastases treated with the Leksell gamma knife: Prognostic factors for patients
31. Surgery versus radiosurgery in the treatment of brain metastasis
32. Surgical treatment of multiple brain metastases
33. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases
34. Preliminary report of RTOG 9508: A phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases
35. Central nervous system metastasis from breast carcinoma. Autopsy study
36. Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience
37. Stereotactic irradiation without whole-brain irradiation for single brain metastasis
38. Is whole-brain radiation therapy needed for all patients with newly diagnosed brain metastases undergoing stereotactic radiosurgery?
39. Radiosurgery for brain metastases: Is whole brain radiotherapy necessary?
40. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both
41. Linac radiosurgery in brain metastases
42. Transient enlargement of contrast uptake on MRI after linear accelerator (Linac) stereotactic radiosurgery for brain metastases
43. Management of brain metastases from breast cancer by combination chemotherapy
44. A phase II randomized trial of synchronous radiotherapy with temozolomide in brain metastases